Arbutus Biopharma
ABUS
ABUS
39 hedge funds and large institutions have $97.6M invested in Arbutus Biopharma in 2014 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 13 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
39
Holders Change
-11
Holders Change %
-22%
% of All Funds
1.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
13
Reduced
13
Closed
18
Calls
$1.47M
Puts
$1.05M
Net Calls
+$419K
Net Calls Change
-$3.88M
Top Buyers
| 1 |
1
AllianceBernstein
Nashville,
Tennessee
|
$9.23M |
| 2 |
2
Renaissance Technologies
New York
|
$1.96M |
| 3 |
3
Millennium Management
New York
|
$1.87M |
| 4 |
4
HSBC Holdings
London,
United Kingdom
|
$1.88M |
| 5 |
5
Franklin Resources
San Mateo,
California
|
$29.7M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
ACM
51
Atika Capital Management
New York
| – | -$279K | -13,000 | Closed |
|
52
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$243K | -11,320 | Closed |
|
|
OAM
53
Orinda Asset Management
Lafayette,
California
| – | -$162K | -7,530 | Closed |
|
|
MAA
54
Managed Account Advisors
Jersey City,
New Jersey
| – | -$35K | -1,607 | Closed |
|
|
QT
55
Quantbot Technologies
New York
| – | -$25K | -1,200 | Closed |
|
|
VIA
56
Vantage Investment Advisors
State College,
Pennsylvania
| – | -$5K | -250 | Closed |
|